Minoxidil before and after: Realistic results and timelines 

DoktorABC editorial team

Accurate, up-to-date health information written by our editorial team and reviewed by UK-registered prescribers.

How minoxidil works and why results vary

Minoxidil is a vasodilator and potassium channel opener. Applied topically, it increases blood flow to hair follicles and prolongs the anagen (active growth) phase of the hair cycle. It does not address the hormonal driver of androgenetic alopecia, which is why it works differently from finasteride and why the two medicines complement each other.

Results vary considerably between individuals. The density of active follicles remaining at the start of treatment is one of the strongest predictors of response. Minoxidil stimulates existing follicles but cannot regenerate those that have been permanently lost. Age, the severity and duration of hair loss, and how consistently the medicine is applied all influence outcomes.

Around two thirds of men who use minoxidil in clinical studies see a cessation of hair loss followed by a period of regrowth that lasts for as long as they continue to apply the solution. This means approximately one third do not see meaningful regrowth, which is an important baseline expectation to carry into treatment.

Minoxidil before and after: Scalp hair loss

The following timeline is based on published clinical trial data, including REGAINE (Regaine 5% solution) clinical studies and peer-reviewed research.

In one study, the average reduction in hair loss severity was 0.85 within 6 months and 1.3 within 12 months, indicating that results continue to improve between the six and twelve month marks. 

Minoxidil before and after: The hairline

The frontal hairline is the area most commonly associated with the visible signs of pattern hair loss, and it is also the area where minoxidil tends to produce the least dramatic results.

Minoxidil is more effective at maintaining and improving density in the crown and mid-scalp than at restoring a receded frontal hairline. This is because hairline recession is often driven by particularly androgen-sensitive follicles that may have a limited response to a vasodilatory treatment alone.

Patients who start minoxidil early, before significant hairline recession has occurred, tend to see better outcomes than those who start later. For men with established hairline recession, managing expectations is important. Minoxidil may slow further recession and improve density behind the hairline, but significant restoration of a receded frontal hairline from topical minoxidil alone is not well supported by the evidence.

Oral minoxidil before and after: How results differ

Oral minoxidil at low doses (typically 0.625 mg to 5 mg daily) is prescribed off-label in the UK for androgenetic alopecia and has attracted growing clinical interest as an alternative to topical application.

A 2025 meta-analysis of 2,933 patients across 27 clinical studies found that 35% of oral minoxidil users experienced significant hair regrowth, 47% showed moderate improvement, and 26% maintained stable hair counts without further loss. This means approximately 82% of patients either improved or held steady. 

A 24-week randomised clinical trial published in JAMA Dermatology in 2024 found that oral minoxidil at 5 mg per day produced similar improvements in terminal hair density compared to 5% topical minoxidil applied twice daily, with oral minoxidil showing superior results specifically in the vertex (crown) area on photographic analysis. 

For oral minoxidil, hair improvement in density and diameter tends to peak at around six months, with results stabilising rather than continuing to increase significantly beyond that point. 

The practical difference between oral and topical is not primarily about efficacy but convenience. Oral minoxidil removes the need for daily scalp application, which improves adherence for many patients.

Minoxidil and finasteride before and after: combined results

Combining minoxidil with finasteride is the most evidence-supported pharmacological approach to androgenetic alopecia, producing better outcomes than either medicine used alone.

Finasteride addresses the hormonal driver of hair loss by reducing DHT; minoxidil stimulates follicular activity independently. The two mechanisms are complementary, which is why their combination is clinically logical.

A randomised comparative study published in Dermatologic Therapy found that combined treatment with oral finasteride and topical minoxidil produced superior results to either monotherapy in men with androgenetic alopecia, with the combination group showing significantly greater improvements in hair density and global photographic assessment. 

In terms of the before and after experience, patients on combination therapy typically notice:

• Earlier stabilisation of hair loss compared to minoxidil alone
• More consistent improvement in both crown and hairline density
• Better maintenance of results over the long term

Results still require patience. The combined benefit becomes most apparent from six months onwards, and twelve months is the more meaningful assessment point for combination treatment.

Minoxidil beard before and after: What to expect

Using minoxidil on the beard is off-label in the UK. The available evidence is limited but encouraging for some men.

A 2024 case report described identical twin males where one applied 5% topical minoxidil daily for over a year to the beard and moustache area. At one month, new finer, lighter-coloured hairs appeared. By two months, a modest increase in facial hair density was noted. A shedding phase occurred at approximately three months, followed by continued progressive growth. After 16 months, the treated twin showed visibly greater beard hair count and density compared to his untreated twin and his own baseline.

Realistic beard before and after expectations:

• Month 1 to 2: Fine, lighter hairs appearing in sparse areas
• Month 3: Possible temporary shedding phase
• Month 6: Modest improvement in coverage for consistent users
• Month 12 to 16: More pronounced improvement in density for responders

Not all men respond, and results depend heavily on the existing density of beard follicles. For areas with no follicles, minoxidil will not produce growth.

Minoxidil eyebrows before and after: Limited evidence

Minoxidil is sometimes used off-label for eyebrow thinning, though the evidence base here is the weakest of all the applications discussed in this guide.

A small number of case reports and observational studies suggest topical minoxidil may improve eyebrow density in some patients, particularly those with eyebrow loss following conditions such as alopecia areata or over-plucking. However, there are no large-scale randomised controlled trials specifically examining minoxidil for eyebrow growth.

Before and after expectations for eyebrows should be very conservative. Some patients report modest improvement over six to twelve months; others see no meaningful change. This remains an area where clinical evidence is insufficient to make reliable predictions.

One year of minoxidil: What changes by the 12-month milestone?

Twelve months is the most clinically meaningful assessment point for minoxidil treatment. By this stage, most patients who are going to respond have done so, and a realistic picture of individual response is available.

For scalp hair loss, consistent users at twelve months typically show:

• Reduced rate of ongoing hair loss
• Improved hair density in the crown and mid-scalp in most responders
• Thicker, stronger existing hairs
• Some recovery of previously thinning areas in good responders

What twelve months of treatment does not typically produce is a full reversal of established pattern hair loss. Minoxidil is most effective at slowing loss and improving density in areas where follicles remain active, not at restoring areas of significant established loss.

Factors that affect your results

• How early treatment starts: Earlier intervention, while more follicles remain active, produces better outcomes
• Consistency of use: Missing doses or applying less than the recommended amount reduces effectiveness
• Severity of hair loss at baseline: Mild to moderate loss responds better than advanced loss
• Age: Younger men with more active follicles tend to respond better than older men with long-established hair loss
• Formulation and frequency: Twice-daily topical application produces better results than once daily; the foam and solution are comparably effective when used correctly
• Combination with finasteride: Consistently associated with better outcomes than minoxidil alone

When to reassess if results are not visible

If you have been using minoxidil consistently for six months and have seen no change in shedding rate, hair density, or texture, a review with your prescriber is appropriate. Possible next steps include:

• Reviewing application technique and frequency
• Considering a switch from topical to oral minoxidil, or vice versa
• Adding finasteride if not already prescribed
• Investigating whether an underlying cause of hair loss has been missed

Do not stop treatment without discussing it with your prescriber. What looks like a lack of response may be stabilisation rather than failure, and stopping may allow further loss that could have been prevented.

Final thoughts

Minoxidil is a genuinely effective treatment for the right patients, used consistently and with realistic expectations. The clinical evidence is clear that most people who respond do so gradually over six to twelve months, that results require ongoing treatment to maintain, and that the best outcomes come from early intervention and, where appropriate, combination with finasteride.

FAQ

The DoktorABC medical advisory board

Dr. Roland Ruiken

Medical advisor, Norway

Dr. Viktor Simunovic

Medical advisor, Croatia

To the medical advisory board